News

06.02.2018

“As an entrepreneur, you have to own up to your decisions”

“As an entrepreneur, you have to own up to your decisions”

Five years ago, Alisée de Tonnac quit her job at L’Oréal and travelled the world to set up the first edition of the startup competition Seedstars World. Five years later, Seedstars is present in more than 85 cities worldwide, runs its own co-working and educational centers and plans to have 15 Seedspaces for co-working and co-living by the end of 2018. BaselArea.swiss sat down with Alisée de Tonnac after her keynote at the Swiss Innovation Forum that took place in Basel last November.

mehr >
21.02.2018

Novartis is World’s Most Innovative Biotech Company

Novartis is World’s Most Innovative Biotech Company

Basel-based pharmaceutical company Novartis has been recognised as the World’s Most Innovative Biotech Company in 2018 by U.S. media brand Fast Company. Novartis was honoured for its pioneering CAR-T cell therapy to fight cancer.

mehr >
20.02.2018

University of Basel creates fintech centre

University of Basel creates fintech centre

With its Center for Innovative Finance, the University of Basel has created a research unit focusing on fintech and blockchain. Big bank Credit Suisse will finance a professorship in blockchain technology.

mehr >
09.01.2018

"We're giving Basel Impact Hub fever"

Impact Hubs are a real success story. Founded in 2005 in London, there are now over 100 Impact Hubs around the world with more than 15,000 members. Following the lead from Bern, Zurich, Geneva and Lausanne, Basel will be the next Impact Hub in Switzerland. The force behind the movement is Hubbasel, an association founded by entrepreneur André Moeri, sustainability expert Connie Low and lawyer Hanna Byland. We wanted to know why an Impact Hub is more than just a coworking space and how entrepreneurs as well as investors and companies benefit from them, so we talked with Hanna Byland to shed some light for us.

mehr >
16.02.2018

Roche accelerates development of cancer treatments

Roche accelerates development of cancer treatments

The Basel-based pharma company Roche is to acquire the U.S. company Flatiron Health, which develops software solutions for use in oncology.

mehr >
15.02.2018

Santhera licenses Polyphor cystic fibrosis drug

Santhera licenses Polyphor cystic fibrosis drug

The pharma company Santhera Pharmaceuticals has obtained the worldwide exclusive license for the product candidate POL6014. Developed by Polyphor, the drug has the potential to treat cystic fibrosis and other diseases.

mehr >
04.12.2017

“Precision medicine is the best opportunity to reconfigure healthcare”

“Precision medicine is the best opportunity to reconfigure healthcare”

After 20 years with the pharmaceutical company Eli Lilly, Bernard Munos set out to better understand pharmaceutical innovation – specifically what makes it possible and how to get more of it. Munos is now a Senior Fellow at Faster Cures, a Center of the Milken Institute, and the founder of the consultancy InnoThink, which advises biomedical research organizations on how to become better innovators. He also contributes to Forbes magazine, an American business publication. Munos travelled to Basel in October, on behalf of HKBB and DayOne to participate in the “Powertalk”.

mehr >
13.02.2018

Basel fights for rail connection

The French side is not giving enough priority to a direct rail connection to the EuroAirport, according to a letter written by the governments of Basel-Stadt and Basel-Landschaft. In it, they call for a binding commitment to finance the connection.

mehr >
13.02.2018

Basel - Weltstadt im Taschenformat

Basel ist die Stadt der kurzen Wege: vom Euroairport gehts zum Messeplatz, vom Zoo in die St. Jakobshalle ans Tennismatch mit Roger Federer. Hochkarätige Museen finden sich an jeder Ecke und Architektur auf Weltklasseniveau begegnet man auf Schritt und Tritt. So präsentiert sich Basel im neuen, knapp fünfminütigen Imagefilm.

mehr >
06.11.2017

“We want to improve the visibility of startups at the University of Basel”

“We want to improve the visibility of startups at the University of Basel”

Christian Elias Schneider has been Head of Innovation at the University of Basel for eight months now. His job is to promote entrepreneurship and projects in collaboration with industry.

mehr >
12.02.2018

Roivant invests in fight against diabetes

Roivant invests in fight against diabetes

Basel-based pharmaceutical company Roivant Sciences has entered into an agreement with Poxel, which will see Roivant receive commercialization rights for the diabetes medication imelglimin as well as a share in the French biopharmaceutical company.

mehr >
08.02.2018

New prosthetic ankle is successfully implanted

New prosthetic ankle is successfully implanted

The world renowned surgeon from Basel, Beat Hintermann, has successfully implanted ankle prosthesis of his own design in five patients in Liestal. Hintermann products are distributed by the U.S. company DT MedTech LLC.

mehr >
03.10.2017

"You should always have something crazy cooking on the back burner"

When Jennifer Doudna gave her keynote at Basel Life in September, the auditorium in the Congress Center was packed. Susan Gasser, Professor of Molecular Biology at the University of Basel introduced Doudna as groundbreaking and extremely innovative. The Professor of Chemistry and of Molecular and Cell Biology at the University of California, Berkeley was on top of Gassers wish list for the Basel Life. The leading figure of what is known as the CRISPR revolution among scientists sat down with BaselArea.swiss during her stay in Basel to talk about her lab, flexible career paths and what makes a great researcher.

mehr >
07.02.2018

Zoetis relocating its Swiss office to the canton of Jura

U.S. global animal health company Zoetis will be managing its Swiss business from Delémont in future. The relocation of the Swiss office to the canton of Jura looks set to create about 10 jobs.

mehr >
06.02.2018

Idorsia moves forward with product candidates

Idorsia moves forward with product candidates

Pharmaceutical research company Idorsia can look back on a successful 2017 fourth quarter. It now aims to bring new compounds into Phase 3 development and turn itself into a profitable company.

mehr >
29.09.2017

Spirochem opens new state-­of-­the-­art Services and R&D facilities in Basel

Spirochem opens new state-­of-­the-­art Services and R&D facilities in Basel

Basel – The fine chemicals company SpiroChem has relocated to state-of-the-art facilities in the Rosental area of Basel, offering the company an ideal location to significantly expand its operations. SpiroChem has also strengthened its board of directors.

mehr >
05.02.2018

Innovation Lounge, un événement unique au Jura

Innovation Lounge, un événement unique au Jura

Le 6 mars prochain se tiendra à Delémont au Cinemont, la deuxième édition de l’événement dédié aux questions du «Tout Connecté».

mehr >
05.02.2018

Unsere Menüempfehlung: Die Food Hackdays

Unsere Menüempfehlung: Die Food Hackdays

An den Open Food Data Hackdays in Basel, die am 16. und 17. Februar in der Alten Markthalle in Basel stattfinden, steht die Ernährung im Zentrum: Gemeinsam arbeiten die Teilnehmenden an Lösungen, um Lebensmittelproduktion und Ernährung transparenter zu gestalten. Neue Herausforderungen, Datensätze und motivierte Teams warten auf alle, die mittels Rapid-Prototyping neue Lösungen für das Nahrungsmittelsystem entwickeln wollen. Das Ziel ist es, revolutionäre Lösungen auf der Grundlage von öffentlich verfügbaren Datensätzen zu entwickeln. Sowohl Entwicklerinnen und Entwickler als auch Köche, Landwirte, Nahrungsmittelexperten, App-Designerinnen oder Unternehmerinnen sind willkommen.

mehr >
18.09.2017

13 startup projects qualify for the first phase of BaseLaunch

13 startup projects qualify for the first phase of BaseLaunch

The BaseLaunch Healthcare Accelerator program from BaselArea.swiss started on September 14. Over 100 applications were received from more than 30 countries, and the selection committee has selected 13 projects to go on to Phase I. Now, the project teams will work with industry experts to further develop their business case over the next three months.

mehr >
05.02.2018

Novartis subsidiary certified as Top Employer

Novartis subsidiary certified as Top Employer

Novartis subsidiary Sandoz has been certified as a Top Employer Europe 2018 for its outstanding employee offerings in Europe and Russia.

mehr >
02.02.2018

Genedata paves way for breakthrough

Genedata paves way for breakthrough

A European research project based on a Genedata platform has made a major breakthrough in the early diagnosis of cancer. Breast and ovarian cancer could be diagnosed earlier than ever before.

mehr >
05.09.2017

"In Switzerland, we often sell promising technologies too early"

Ulf Claesson is a "serial entrepreneur". During the past 25 years, he has set up companies that have gone on to become firmly established in the market. In 2012, he joined Clinerion as CEO and shareholder. Since then, the company has positioned itself in the medical data field and recently entered into a partnership with British company Cisiv. Clinerion's software helps recruit patients for clinical trials run by major pharmaceutical companies – in real time. But the competition never sleeps. A growing number of competitors is now appearing, especially in the USA where there is no shortage of risk capital. In this interview for the Innovation Report, Claesson explains how the Basel-based healthtech company plans to maintain its leadership position.

mehr >
01.02.2018

Record level of VC investment in Switzerland

Record level of VC investment in Switzerland

Funding for Swiss startups reached a new record high in 2017. The greatest rise was reported for venture capital investment in fintechs in the area of digitalisation. Biotech and medtech continued to receive the highest amounts.

mehr >
30.01.2018

BaseLaunch up to a solid Phase II start

BaseLaunch up to a solid Phase II start

BaseLaunch has officially started Phase II of its accelerator program, and four startups are receiving grants ranging from 120,000 to 250,000 Swiss francs. This non-dilutive funding will help them to reach key value inflection milestones to advance their scientific hypothesis and further build their ventures, while learning and benefiting from the Basel life sciences ecosystem. Furthermore, two startups will gain access to the ready-to-use laboratory and office space, both free of charge, at the Switzerland Innovation Park Basel Area.

mehr >
04.07.2017

"I want to turn innovative research into new drugs"

Cellestia CEO Michael Bauer.

Each year some 250,000 patients develop a type of cancer because of faulty communication between cells. This malfunction occurs in what is known as the NOTCH signal path. There are currently no effective treatments – but this is set to change. Cellestia Biotech AG is developing an innovative drug against this type of cancer by using a novel active ingredient that selectively attacks the malfunctioning cell communication. The drug could be used to treat leukaemia, lymphomas and solid tumours such as breast cancer.

mehr >
29.01.2018

First FutureHealth Basel was a success

First FutureHealth Basel was a success

The first FutureHealth Basel was held on Friday in Basel, with speakers discussing key changes in the healthcare sector. 350 guests attended the successful premiere with its international appeal.

mehr >
26.01.2018

BaselArea.swiss und Switzerland Innovation Park Basel Area rücken näher zusammen

BaselArea.swiss, die Innovationsförderung und Standortpromotion der Kantone Basel-Landschaft, Basel-Stadt und Jura, übernimmt ab März 2018 im Mandat die Geschäftsführung der Switzerland Innovation Park Basel Area AG. Gleichzeitig prüfen die Trägerkantone eine Fusion der beiden Organisationen.

mehr >
13.06.2017

Roivant is creating a buzz in Basel

Roivant is creating a buzz in Basel

Roivant Sciences, a fast-growing life sciences company from the US, recently opened its global headquarters in Basel. In celebration of their newly established location, Roivant, together with BaselArea.swiss, invited stakeholders from the life sciences sector to “Halle 7, Gundeldingerfeld” in Basel on June 8th 2017 for a panel discussion on the future of healthcare.

mehr >
25.01.2018

Baloise expands digital services

The insurance company Baloise has launched an additional digital service. Mobly, a mobility platform for car owners, expands Baloise’s traditional insurance business.

mehr >
24.01.2018

Blockchain sector comes to Basel

Hyperledger, a platform to advance blockchain technologies, is hosting this year’s Hyperledger Global Forum at the Congress Center Basel. The event will showcase the potential of different blockchain applications.

mehr >
08.06.2017

BaselArea.swiss got off to a successful start

BaselArea.swiss got off to a successful start

In its first annual report, the newly formed BaselArea.swiss can look back on a successful 2016. The joint initiative for innovation and economic promotion by the cantons of Basel-Stadt, Basel-Landschaft and Jura succeeded in growing in all areas. It provided assistance to 36 companies moving to the region, which corresponds to a 50% increase over the previous year. In the area of innovation promotion, over 4,000 participants attended 80 events, expanding the regional network from 8,000 to 13,000 innovators and experts. The services provided by BaselArea.swiss were also actively used to promote start-up projects, contributing to 43 companies being founded.

mehr >
24.01.2018

U.S. study names Switzerland best country in the world

U.S. study names Switzerland best country in the world

Switzerland has been named “the best country in the world” by a new study, standing out in particular for its business-friendly environment.

mehr >
23.01.2018

Basel researchers create images of atoms

Basel researchers create images of atoms

Scientists in Basel have now succeeded in creating images of quantum dots thanks to a novel optical technology. Their development could be of interest for quantum mechanics.

mehr >
08.06.2017

A molecular assembly line to cure the body

A molecular assembly line to cure the body

Imagine that certain forms of blindness could be cured. Or imagine that the body itself could produce a cure for some of its own diseases. These may be just some of the results of the National Centre of Competence in Research Molecular Systems Engineering (NCCR MSE). Its long-term goals are to create molecular systems and factories for the production of high added-value chemicals and develop cellular systems for new applications in medical diagnostics, therapy and treatment. Director Thomas Ward is aiming high: He wants to make Basel the leading hub for the next European flagship project. At stake: one billion euro.

mehr >
23.01.2018

Skilled talent loves Switzerland

Skilled talent loves Switzerland

Switzerland again took first place in the global competition for attracting the best talent. It scored especially well for its high quality of life, its dual-education system and its strong regulatory environment.

mehr >
22.01.2018

Basel – a welcoming city for expatriates

Basel – a welcoming city for expatriates

I am proud of my hometown Basel. Having travelled extensively, I value the benefits of living in a friendly, beautiful, and multi-cultural city.

mehr >
15.05.2017

Investing in strengths – Swiss leadership in life sciences

Investing in strengths – Swiss leadership in life sciences

How can Switzerland and the Basel region maintain their international leadership role in life sciences? As part of the Biotech and Digitization Day, Federal Councillor Johann Schneider-Ammann visited the Basel region to discuss current trends and challenges with a high-ranking delegation from politics, business, research and start-ups.

mehr >
22.01.2018

uptownBasel – the first state-of-the-art Industry 4.0 campus in Switzerland

uptownBasel – the first state-of-the-art Industry 4.0 campus in Switzerland

In Arlesheim (Canton Basel-Land) just south of the city of Basel, uptownBasel AG is developing Switzerland's first Industry 4.0 campus. The site covers 70,000 square metres, has 750 parking spaces, and a direct motorway connection. Buses and trams also stop right at the doorstep. This all means the campus is ideally positioned to transform itself into a magnet for high-tech businesses over the coming years.

mehr >
22.01.2018

Roche to cooperate with antibody supplier

Roche to cooperate with antibody supplier

Basel-based pharmaceutical company Roche will collaborate with the life science online retailer Abcam to allow researchers to order antibodies for research purposes. Roche is making available a portfolio of antibodies.

mehr >
09.05.2017

The healthcare system must take responsibility

The healthcare system must take responsibility

Kristian Schneider wants to improve the quality of health care and better manage the rising healthcare costs by means of a network that includes doctors, hospitals, insurance companies and the state. Its aim is to provide exactly those services needed for the health of patients. For the canton of Jura, which like all other cantons suffers from the fragmentation of service providers, this could be a unique opportunity to build an integrative care system – and thus become a pioneer, says the director of Hôpital du Jura.

mehr >

 

(Source: http://www.baselarea.swiss/en/baselarea-swiss/channels/innovation-report.html)